The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels

被引:28
作者
Anderson, Paul H. [1 ,2 ]
Lee, Alice M. [1 ,2 ]
Anderson, Sarah M. [1 ]
Sawyer, Rebecca K. [1 ]
O'Loughlin, Peter D. [1 ,2 ]
Morris, Howard A. [1 ,2 ,3 ]
机构
[1] SA Pathol, Chem Pathol, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Fac Hlth Sci, Sch Med Sci, Adelaide, SA 5005, Australia
[3] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia
关键词
25-Hydroxyvitamin D; Calcium; 25-Hydroxyvitamin-D-1; alpha-hydroxylase; Liver; VITAMIN-D-RECEPTOR; MESSENGER-RNA; HUMAN CYP3A4; EXPRESSION; HEPATOCYTES; CYP27B1; CELLS;
D O I
10.1016/j.jsbmb.2010.03.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin D depletion in rats causes osteopenia in at least three skeletal sites. However it is unclear whether modulation of dietary calcium intake impacts on the relationship between the level of serum 25-hydroxyvitamin D (25D) and bone loss. Nine-month-old female Sprague-Dawley rats (n = 5-6/group) were pair-fed a semi-synthetic diet containing either 0 or 20IU vitamin D3/day with either low (0.1%) or high (1%) dietary Ca for 6 months. At 15 months of age, fasting bloods were collected for biochemical analyses. Serum 25D levels were lowest in the animals fed 0 IU vitamin D and 0.1% Ca. The animals fed 1% Ca had significantly higher serum 25D levels when compared to animals fed 0.1% Ca (P < 0.05). The major determinants of serum 250 were dietary vitamin D and dietary calcium (Multiple R = 0.75, P < 0.05). Animals fed 0.1% Ca had higher renal CYP27B1 mRNA expression and 12-18-fold increased levels of serum 1,25D. Hence, the reported effects of low calcium diets on bone loss may be, in part, due to the subsequent effects of 25D metabolism leading to reduction in vitamin D status. Such an interaction has significant implications, given the recent evidence for local synthesis of active vitamin D in bone tissue. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 17 条
[1]   RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells [J].
Anderson, P. H. ;
Atkins, G. J. ;
Findlay, D. M. ;
Oloughlin, P. D. ;
Welldon, K. ;
Vincent, C. ;
Morris, H. A. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :601-605
[2]   Vitamin D Depletion Induces RANKL-Mediated Osteoclastogenesis and Bone Loss in a Rodent Model [J].
Anderson, Paul H. ;
Sawyer, Rebecca K. ;
Moore, Alison J. ;
May, Brian K. ;
O'Loughlin, Peter D. ;
Morris, Howard A. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (11) :1789-1797
[3]   Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction [J].
Anderson, PH ;
O'Loughlin, PD ;
May, BK ;
Morris, HA .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 31 (01) :123-132
[4]  
ANDERSON PH, 2005, VITAMIN D, V1, P711
[5]   Metabolism of vitamin D3 in human osteoblasts:: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3 [J].
Atkins, Gerald J. ;
Anderson, Paul H. ;
Findlay, David M. ;
Welldon, Katie J. ;
Vincent, Cristina ;
Zannettino, Andrew C. W. ;
O'Loughlin, Peter D. ;
Morris, Howard A. .
BONE, 2007, 40 (06) :1517-1528
[6]   1-ALPHA,25-DIHYDROXYVITAMIN-D3-INDUCED INCREMENTS IN HEPATOCYTE CYTOSOLIC CALCIUM AND LYSOPHOSPHATIDYLINOSITOL - INHIBITION BY PERTUSSIS TOXIN AND 1-BETA,25-DIHYDROXYVITAMIN-D3 [J].
BARAN, DT ;
SORENSEN, AM ;
HONEYMAN, TW ;
RAY, R ;
HOLICK, MF .
JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (05) :517-524
[7]   A NEW MECHANISM FOR INDUCED VITAMIN-D DEFICIENCY IN CALCIUM DEPRIVATION [J].
CLEMENTS, MR ;
JOHNSON, L ;
FRASER, DR .
NATURE, 1987, 325 (6099) :62-65
[8]   Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease [J].
Davies, M ;
Heys, SE ;
Selby, PL ;
Berry, JL ;
Mawer, EB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :209-212
[9]   Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes [J].
Drocourt, L ;
Ourlin, JC ;
Pascussi, JM ;
Maurel, P ;
Vilarem, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25125-25132
[10]  
Galisteo M, 1999, J PHARMACOL EXP THER, V290, P1270